These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6214925

  • 1. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A.
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A, Jostell KG, Ross SB, Westerlund D.
    Psychopharmacology (Berl); 1981 Jul; 74(4):297-305. PubMed ID: 6457309
    [Abstract] [Full Text] [Related]

  • 6. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
    Aberg-Wistedt A.
    Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
    [Abstract] [Full Text] [Related]

  • 7. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA, McAuley R, Rani SJ, Roy D, Montgomery DB.
    Acta Psychiatr Scand Suppl; 1981 Aug; 290():314-27. PubMed ID: 6452798
    [Abstract] [Full Text] [Related]

  • 8. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E, Salminen J, Lehtinen V.
    J Int Med Res; 1982 Aug; 10(4):250-6. PubMed ID: 6214441
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
    Potter WZ, Calil HM, Extein I, Muscettola G, Goodwin FK.
    Psychopharmacol Bull; 1981 Jan; 17(1):26-9. PubMed ID: 6453356
    [No Abstract] [Full Text] [Related]

  • 13. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A, Krakowski M, Gershon S.
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The antidepressant efficacy of zimelidine and maprotiline.
    Montgomery SA, Rani SJ, McAuley R, Roy D, Montgomery DB.
    Acta Psychiatr Scand Suppl; 1981 Aug; 290():219-24. PubMed ID: 6452792
    [Abstract] [Full Text] [Related]

  • 17. Zimelidine vs maprotiline in depressed outpatients. A preliminary report.
    d'Elia G, Hällström T, Nyström C, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1981 Aug; 290():225-35. PubMed ID: 6452793
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Zimelidine: comparison of different dosage regimes in general practice.
    Watson JM, Tiplady B.
    Acta Psychiatr Scand Suppl; 1981 Aug; 290():464-70. PubMed ID: 6452806
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.